Lucy Phillips
Company: Abbvie
Job title: Senior Principal Pathologist
Bio:
Lucy Phillips is a senior principal pathologist at Abbvie, where her work focuses on Immunology research, principally in rheumatoid arthritis and inflammatory bowel disease. During her 18 years in drug discovery research, Lucy has successfully navigated the shift from traditional glass slide-based pathology to a fully digitized laboratory. She leads the image analysis team, who develop quantitative histologic end points for efficacy studies, biomarker quantitation and target validation studies using Visiopharm software. She also leads the Spatialomics team who perform high dimensional transcriptomics and proteomics assays on human tissues to reveal novel insights into disease pathogenesis and explore novel targets. Her talk will focus on ways the team have successfully integrated data across modalities and leveraged Visiopharm H&E algorithms to apply macro-segmentation to spatial images enabling a more detailed analysis of tissue compartments.
Seminars:
Integrating Image Analysis & Spatial Technologies to Advance Quantitative Biomarker Discovery in Preclinical Studies 11:30 am
Showcasing workflows to automate H&E and IHC image analysis for improved biomarker quantitation in rodent and human tissues Exploring the integration of spatial proteomics and transcriptomics to enhance biomarker validation and tissue segmentation Sharing key challenges, practical lessons, and future opportunities for applying spatial image analysis in preclinical drug discoveryRead more
day: Conference Day One
8:50 am Chair’s Opening Remarks 8:50 am
day: Conference Day One
5:00 pm Chair’s Closing Remarks 5:00 pm
day: Conference Day One
Panel Discussion: Ensuring Fit for Purpose AI in Translational & Clinical Pathology to Accelerate Meaningful & Scalable Adoption 12:15 pm
How does biopharma define and measure whether a digital pathology tool is fit for its intended use case in drug development or diagnostics? What benchmarking strategies help distinguish generalizable models from those validated for specific clinical or biomarker contexts? How can pathologists and data scientists work together to align model development with real-world use requirements?Read more
day: Conference Day Two